14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
PACS vs CON: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
CON Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 6–4 Matrix Metrics)
CON Overall Winner
6-Pillar Tally: PACS 2 – 4 CON
Matrix Metrics: PACS 4 – 6 CON
As of Nov 20, 2026, Concentra Group Holdings Parent, Inc. (CON) is the stronger overall head-to-head candidate over PACS Group, Inc. (PACS) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, Options & Positioning). PACS carries a Unified Composite Score of 46.8/100 (HOLD) at $43.67 (15.3x Forward P/E, 7.4% operating margin), whereas CON carries 43.5/100 (HOLD) at $41.84 (22.0x Forward P/E, 17.2% operating margin).
Composite vs. Pillar Nuance: While PACS currently prints a higher short-term Unified Composite Score (46.8/100 HOLD vs. CON 43.5/100 HOLD), CON captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (17.2% vs. 7.4% operating margin) and revenue trajectory (+8.6% vs. +11.5% YoY).
Competes within the Medical Care Facilities value chain with $6.8B market capitalization and 7.4% operating margin.
OpEx & R&D Reinvestment10.4% of Rev ($593M)
90D Engineering Disclosures0 Published
CON Moat ProfileHigh-Margin Pricing Power Moat
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $5.2B market capitalization and 17.2% operating margin.
OpEx & R&D Reinvestment12.7% of Rev ($297M)
90D Engineering Disclosures0 Published
Investor FAQ PACS vs CON Key Questions & Quantitative Answers
As of Nov 20, 2026, Concentra Group Holdings Parent, Inc. (CON) is the stronger overall head-to-head candidate over PACS Group, Inc. (PACS) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, Options & Positioning). PACS carries a Unified Composite Score of 46.8/100 (HOLD) at $43.67 (15.3x Forward P/E, 7.4% operating margin), whereas CON carries 43.5/100 (HOLD) at $41.84 (22.0x Forward P/E, 17.2% operating margin). Composite vs. Pillar Nuance: While PACS currently prints a higher short-term Unified Composite Score (46.8/100 HOLD vs. CON 43.5/100 HOLD), CON captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (17.2% vs. 7.4% operating margin) and revenue trajectory (+8.6% vs. +11.5% YoY).
PACS leads the Growth & Scale pillar: PACS posts +11.5% YoY revenue growth and +15.6% YoY earnings growth on $5.71B TTM revenue (17.8% gross margin, 7.4% operating margin), compared with CON at +8.6% YoY revenue growth and +36.4% YoY earnings growth on $2.34B TTM revenue (29.9% gross margin, 17.2% operating margin). Across the 4-period historical trajectory (FY2022 to FY2025), PACS cumulative revenue shifted +120.4% while CON shifted +25.6%. In operating R&D and SG&A reinvestment, PACS deploys 10.4% of Rev ($593M) (0 90-day corporate R&D disclosures) versus 12.7% of Rev ($297M) (0 disclosures) for CON.
PACS screens cheaper on headline valuation multiples. PACS trades at 15.3x Forward P/E, 26.2x Trailing P/E, 1.22x PEG, and 1.8x EV/Revenue (0.1% FCF margin), whereas CON trades at 22.0x Forward P/E, 24.5x Trailing P/E, N/M PEG, and 3.1x EV/Revenue (11.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PACS (26.5% ROE) versus CON (47.2% ROE) capital efficiency.
In options market volatility and institutional positioning, PACS carries 46.1% implied volatility (11th %ile, Compressed (<25th %ile)), a 0.52x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.78β · 51% Vol realized risk). By comparison, CON carries 269.9% implied volatility (95th %ile, Extreme (>80th %ile)), a 0.79x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKOUT options structure phase (0.52β · 38% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.